TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 18 February 2020 |
| Author/s |
author: Hope Rugo Minetta C Liu William E Grizzle Nancy U Lin Christos Vaklavas |
| Publication date | February 18, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |